Al Ahly Pharos

Pre-Session Views

Al Ahly Pharos

In today's views

  • Strategy | Reiterating small-cap pharma call: Nile Pharma bubble crashed and Memphis Pharma will likely outperform in 2026
  • MFPC roundtable takeaways | Structural export advantage reinforced, limited CBAM risk, and clear investment path ahead
  • ​CICH | 9M25 resilience underscores our EGP13/share fair value
  • TWSA | Preliminary indicators show promising growth in factoring